Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma (Q33382596)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37369294)
(P304) 740-745
(P407) (Q1860)
(P433) 5
(P478) 27
(P577) Monday, December 29, 2008
(P921) (Q42824440)
(Q413299)
(Q282142)
(Q412197)
(Q16909647)
(P1433) (Q400292)
(P1476) "Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma" (language: en)
(P2093) Teri N Kreisl
Lyndon Kim
Kraig Moore
Paul Duic
Cheryl Royce
Irene Stroud
Nancy Garren
Megan Mackey
Kevin Camphausen
John Park
Paul S Albert
Howard A Fine
(P2860) (Q37036914)
(Q35688316)
(Q36599884)
(Q30444953)
(Q27860910)
(Q35800783)
(Q35800712)
(Q35650045)
(Q40789890)
(Q48794685)
(Q48486587)
(Q48267884)
(Q46942082)
(Q48264845)
(Q46512529)
(Q46502913)
(Q47378801)
(Q55473747)
(Q44781447)
(Q81740171)
other details
description scientific article

External Links